Back

Baroreflex-activation-therapy in advanced heart failure: do patients accept an additional device-based therapy when symptomatic under optimized treatment?

26 May 2018 (08:30 - 18:30)
Organised by:
Congress Presentation Part of: HF-DACH Poster session - Chronic Heart Failure – Treatment Devices for Autonomic Modulation HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Denise Guckel

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

1 More presentation in this session

Presentation thumbnail
Doctor N. Pavo (Vienna, AT)
Abstract

Access the full session

Session thumbnail
HF-DACH Poster session - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Baroreflex activation therapy in HFrEF patients: international strategies for patient selection and management
12 May 2024
thumbnail
Congress Presentation
Real-world implementation of guideline-directed treatment in advanced heart failure: single center experience
20 May 2023
thumbnail
Congress Presentation
Chemoreflex and baroreflex dysfunction still predict cardiovascular mortality and hospitalizations in patients with systolic heart failure and up-to-date treatment
29 June 2021
thumbnail
Congress Session
Which device might help your HFpEF patient?
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources